1.
Burri E, Juillerat P, Maillard MH, Manz M, Michetti P, Mottet C, Rogler G, Zahnd N, Vavricka S. Position statement on the use of biosimilars in inflammatory bowel disease. Swiss Med Wkly [Internet]. 2019 Dec. 2 [cited 2024 Mar. 28];149(4950):w20148. Available from: https://smw.ch/index.php/smw/article/view/2696